Evaluation of the RHAM-based Pluslife Rapid SARS-CoV-2 assay and comparison with EasyNAT Rapid SARS-CoV-2 assay and Wondfo 2019-nCoV antigen assay

ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains a significant public health challenge. This study evaluated the Pluslife SARS-CoV-2 assay employing proprietary RNase Hybridization-Assisted amplification (RHAM) isothermal amplification technology, with comparative perfor...

Descripció completa

Dades bibliogràfiques

Autors principals:	Guosheng Zhong, Zhiwei Zhao, Yuting He, Xuegao Yu, Tingting Yang, Huanliang Liu, Shibing Li, Cha Chen, Mingyong Luo, Bin Huang
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology 2025-12-01
Col·lecció:	Microbiology Spectrum
Matèries:	SARS-CoV-2 isothermal amplification POCT RT-qPCR Pluslife Rapid SARS-CoV-2 assay EasyNAT Rapid SARS-CoV-2 assay
Accés en línia:	https://journals.asm.org/doi/10.1128/spectrum.03418-24
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!